10-[8-[4,6-bis(4-methylphenyl)pyrimidin-2-yl]-5,12-dihydrotetracen-2-yl]-9,9-dimethylacridine;2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide;8-[4-(3,5-dimethylphenyl)-6-ethylquinolin-8-yl]-N,N-bis(4-methylphenyl)-6,11-dihydrotetracen-2-amine;8-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-N,N-bis(3-methylphenyl)-6,11-dihydrotetracen-2-amine;5-[8-(4-methyl-N-(4-methylphenyl)anilino)-6,11-dihydrotetracen-2-yl]benzene-1,3-dicarbonitrile

C239H187N13O2S2 — CID 161249741

IUPAC10-[8-[4,6-bis(4-methylphenyl)pyrimidin-2-yl]-5,12-dihydrotetracen-2-yl]-9,9-dimethylacridine;2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide;8-[4-(3,5-dimethylphenyl)-6-ethylquinolin-8-yl]-N,N-bis(4-methylphenyl)-6,11-dihydrotetracen-2-amine;8-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-N,N-bis(3-methylphenyl)-6,11-dihydrotetracen-2-amine;5-[8-(4-methyl-N-(4-methylphenyl)anilino)-6,11-dihydrotetracen-2-yl]benzene-1,3-dicarbonitrile
SMILESCC1(C)c2ccccc2N(c2ccc3cc4c(cc3c2)Cc2ccc(-c3ccc5c(c3)Sc3ccccc3S5(=O)=O)cc2C4)c2ccccc21.CCc1cc(-c2ccc3c(c2)Cc2cc4ccc(N(c5ccc(C)cc5)c5ccc(C)cc5)cc4cc2C3)c2nccc(-c3cc(C)cc(C)c3)c2c1.Cc1ccc(-c2cc(-c3ccc(C)cc3)nc(-c3ccc4cc5c(cc4c3)Cc3ccc(N4c6ccccc6C(C)(C)c6ccccc64)cc3C5)n2)cc1.Cc1ccc(N(c2ccc(C)cc2)c2ccc3c(c2)Cc2cc4ccc(-c5cc(C#N)cc(C#N)c5)cc4cc2C3)cc1.Cc1cccc(N(c2cccc(C)c2)c2ccc3cc4c(cc3c2)Cc2ccc(-c3ccc(-c5nnc(-c6ccccc6)n5-c5ccccc5)cc3)cc2C4)c1
InChIInChI=1S/C52H40N4.C51H41N3.C51H44N2.C45H33NO2S2.C40H29N3/c1-35-11-9-17-48(27-35)55(49-18-10-12-36(2)28-49)50-26-25-42-31-44-32-43-29-40(23-24-41(43)30-45(44)33-46(42)34-50)37-19-21-39(22-20-37)52-54-53-51(38-13-5-3-6-14-38)56(52)47-15-7-4-8-16-47;1-32-13-17-34(18-14-32)46-31-47(35-19-15-33(2)16-20-35)53-50(52-46)38-22-21-36-25-41-29-42-30-43(24-23-37(42)26-40(41)28-39(36)27-38)54-48-11-7-5-9-44(48)51(3,4)45-10-6-8-12-49(45)54;1-6-36-24-49(51-50(25-36)48(19-20-52-51)44-22-34(4)21-35(5)23-44)39-12-11-37-26-42-30-43-31-47(18-13-38(43)27-41(42)29-40(37)28-39)53(45-14-7-32(2)8-15-45)46-16-9-33(3)10-17-46;1-45(2)37-9-3-5-11-39(37)46(40-12-6-4-10-38(40)45)36-19-17-30-23-33-24-32-21-28(15-16-29(32)22-34(33)25-35(30)26-36)31-18-20-44-42(27-31)49-41-13-7-8-14-43(41)50(44,47)48;1-26-3-10-38(11-4-26)43(39-12-5-27(2)6-13-39)40-14-9-32-20-35-21-34-18-30(33-16-28(24-41)15-29(17-33)25-42)7-8-31(34)19-36(35)22-37(32)23-40/h3-29,31,33-34H,30,32H2,1-2H3;5-25,27-28,30-31H,26,29H2,1-4H3;7-25,27-28,30-31H,6,26,29H2,1-5H3;3-21,23,25-27H,22,24H2,1-2H3;3-19,21,23H,20,22H2,1-2H3
InChIKeyVBCONSFVMNJRCT-UHFFFAOYSA-N
MW3337.35 g/mol
LogP60.58
Rot. Bonds23

About 10-[8-[4,6-bis(4-methylphenyl)pyrimidin-2-yl]-5,12-dihydrotetracen-2-yl]-9,9-dimethylacridine;2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide;8-[4-(3,5-dimethylphenyl)-6-ethylquinolin-8-yl]-N,N-bis(4-methylphenyl)-6,11-dihydrotetracen-2-amine;8-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-N,N-bis(3-methylphenyl)-6,11-dihydrotetracen-2-amine;5-[8-(4-methyl-N-(4-methylphenyl)anilino)-6,11-dihydrotetracen-2-yl]benzene-1,3-dicarbonitrile

10-[8-[4,6-bis(4-methylphenyl)pyrimidin-2-yl]-5,12-dihydrotetracen-2-yl]-9,9-dimethylacridine;2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide;8-[4-(3,5-dimethylphenyl)-6-ethylquinolin-8-yl]-N,N-bis(4-methylphenyl)-6,11-dihydrotetracen-2-amine;8-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-N,N-bis(3-methylphenyl)-6,11-dihydrotetracen-2-amine;5-[8-(4-methyl-N-(4-methylphenyl)anilino)-6,11-dihydrotetracen-2-yl]benzene-1,3-dicarbonitrile (PubChem CID 161249741) has the molecular formula C239H187N13O2S2 and a molecular weight of 3337.35 g/mol. Its IUPAC name is 10-[8-[4,6-bis(4-methylphenyl)pyrimidin-2-yl]-5,12-dihydrotetracen-2-yl]-9,9-dimethylacridine;2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide;8-[4-(3,5-dimethylphenyl)-6-ethylquinolin-8-yl]-N,N-bis(4-methylphenyl)-6,11-dihydrotetracen-2-amine;8-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-N,N-bis(3-methylphenyl)-6,11-dihydrotetracen-2-amine;5-[8-(4-methyl-N-(4-methylphenyl)anilino)-6,11-dihydrotetracen-2-yl]benzene-1,3-dicarbonitrile.

Molecular Properties

Compound Name10-[8-[4,6-bis(4-methylphenyl)pyrimidin-2-yl]-5,12-dihydrotetracen-2-yl]-9,9-dimethylacridine;2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide;8-[4-(3,5-dimethylphenyl)-6-ethylquinolin-8-yl]-N,N-bis(4-methylphenyl)-6,11-dihydrotetracen-2-amine;8-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-N,N-bis(3-methylphenyl)-6,11-dihydrotetracen-2-amine;5-[8-(4-methyl-N-(4-methylphenyl)anilino)-6,11-dihydrotetracen-2-yl]benzene-1,3-dicarbonitrile
PubChem CID161249741
Molecular FormulaC239H187N13O2S2
Molecular Weight3337.35 g/mol
Exact Mass3334.44
IUPAC Name10-[8-[4,6-bis(4-methylphenyl)pyrimidin-2-yl]-5,12-dihydrotetracen-2-yl]-9,9-dimethylacridine;2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide;8-[4-(3,5-dimethylphenyl)-6-ethylquinolin-8-yl]-N,N-bis(4-methylphenyl)-6,11-dihydrotetracen-2-amine;8-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-N,N-bis(3-methylphenyl)-6,11-dihydrotetracen-2-amine;5-[8-(4-methyl-N-(4-methylphenyl)anilino)-6,11-dihydrotetracen-2-yl]benzene-1,3-dicarbonitrile
SMILESCC1(C)c2ccccc2N(c2ccc3cc4c(cc3c2)Cc2ccc(-c3ccc5c(c3)Sc3ccccc3S5(=O)=O)cc2C4)c2ccccc21.CCc1cc(-c2ccc3c(c2)Cc2cc4ccc(N(c5ccc(C)cc5)c5ccc(C)cc5)cc4cc2C3)c2nccc(-c3cc(C)cc(C)c3)c2c1.Cc1ccc(-c2cc(-c3ccc(C)cc3)nc(-c3ccc4cc5c(cc4c3)Cc3ccc(N4c6ccccc6C(C)(C)c6ccccc64)cc3C5)n2)cc1.Cc1ccc(N(c2ccc(C)cc2)c2ccc3c(c2)Cc2cc4ccc(-c5cc(C#N)cc(C#N)c5)cc4cc2C3)cc1.Cc1cccc(N(c2cccc(C)c2)c2ccc3cc4c(cc3c2)Cc2ccc(-c3ccc(-c5nnc(-c6ccccc6)n5-c5ccccc5)cc3)cc2C4)c1
InChIInChI=1S/C52H40N4.C51H41N3.C51H44N2.C45H33NO2S2.C40H29N3/c1-35-11-9-17-48(27-35)55(49-18-10-12-36(2)28-49)50-26-25-42-31-44-32-43-29-40(23-24-41(43)30-45(44)33-46(42)34-50)37-19-21-39(22-20-37)52-54-53-51(38-13-5-3-6-14-38)56(52)47-15-7-4-8-16-47;1-32-13-17-34(18-14-32)46-31-47(35-19-15-33(2)16-20-35)53-50(52-46)38-22-21-36-25-41-29-42-30-43(24-23-37(42)26-40(41)28-39(36)27-38)54-48-11-7-5-9-44(48)51(3,4)45-10-6-8-12-49(45)54;1-6-36-24-49(51-50(25-36)48(19-20-52-51)44-22-34(4)21-35(5)23-44)39-12-11-37-26-42-30-43-31-47(18-13-38(43)27-41(42)29-40(37)28-39)53(45-14-7-32(2)8-15-45)46-16-9-33(3)10-17-46;1-45(2)37-9-3-5-11-39(37)46(40-12-6-4-10-38(40)45)36-19-17-30-23-33-24-32-21-28(15-16-29(32)22-34(33)25-35(30)26-36)31-18-20-44-42(27-31)49-41-13-7-8-14-43(41)50(44,47)48;1-26-3-10-38(11-4-26)43(39-12-5-27(2)6-13-39)40-14-9-32-20-35-21-34-18-30(33-16-28(24-41)15-29(17-33)25-42)7-8-31(34)19-36(35)22-37(32)23-40/h3-29,31,33-34H,30,32H2,1-2H3;5-25,27-28,30-31H,26,29H2,1-4H3;7-25,27-28,30-31H,6,26,29H2,1-5H3;3-21,23,25-27H,22,24H2,1-2H3;3-19,21,23H,20,22H2,1-2H3
InChIKeyVBCONSFVMNJRCT-UHFFFAOYSA-N
XLogP60.58
TPSA167.30 Ų
H-Bond Donors
H-Bond Acceptors16
Rotatable Bonds23
Heavy Atoms256
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003337.35
LogP ≤ 560.58
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1016

Analyze 10-[8-[4,6-bis(4-methylphenyl)pyrimidin-2-yl]-5,12-dihydrotetracen-2-yl]-9,9-dimethylacridine;2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide;8-[4-(3,5-dimethylphenyl)-6-ethylquinolin-8-yl]-N,N-bis(4-methylphenyl)-6,11-dihydrotetracen-2-amine;8-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-N,N-bis(3-methylphenyl)-6,11-dihydrotetracen-2-amine;5-[8-(4-methyl-N-(4-methylphenyl)anilino)-6,11-dihydrotetracen-2-yl]benzene-1,3-dicarbonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide
CID 139335250
2-[4-(9,9-dimethylacridin-10-yl)phenyl]thianthrene 5,5-dioxide
CID 155244685
2-(8-carbazol-9-yl-5,12-dihydrotetracen-2-yl)-10,10-diphenylbenzo[b][1,4]benzothiasiline 5,5-dioxide;9-[3,5-dimethyl-4-[8-(5-quinoxalin-5-ylthiophen-2-yl)-6,11-dihydrotetracen-2-yl]phenyl]carbazole;9-[8-(1,2-diphenylbenzimidazol-5-yl)-5,12-dihydrotetracen-2-yl]carbazole;3-(2-ethylthieno[3,2-b]thiophen-5-yl)-5-[8-(N-phenylanilino)-6,11-dihydrotetracen-2-yl]benzonitrile
CID 159756387
N-[4-[9,9-dimethyl-10-(4-phenylphenyl)acridin-2-yl]phenyl]-3-methyl-N-(3-methylphenyl)aniline
CID 89457849
N-[4-[4-(N-(9,9-dimethyl-7,10-diphenylacridin-2-yl)anilino)phenyl]phenyl]-9,9-dimethyl-N,7,10-triphenylacridin-2-amine;N-[4-[4-(N-[9,9-dimethyl-10-(4-methylphenyl)-7-phenylacridin-2-yl]anilino)phenyl]phenyl]-9,9-dimethyl-10-(4-methylphenyl)-N,7-diphenylacridin-2-amine;N-[4-[4-(N-(9,9-dimethyl-10-naphthalen-1-yl-7-phenylacridin-2-yl)anilino)phenyl]phenyl]-9,9-dimethyl-10-naphthalen-1-yl-N,7-diphenylacridin-2-amine;N-[4-[4-[(9,9-dimethyl-10-phenylacridin-2-yl)-naphthalen-1-ylamino]phenyl]phenyl]-9,9-dimethyl-N-naphthalen-2-yl-10-phenylacridin-2-amine;N-[4-[4-[[9,9-dimethyl-10-(4-phenylphenyl)acridin-2-yl]-naphthalen-1-ylamino]phenyl]phenyl]-9,9-dimethyl-N-naphthalen-2-yl-10-(4-phenylphenyl)acridin-2-amine
CID 159235712
5-(8-phenoxazin-10-yl-5,12-dihydrotetracen-2-yl)benzene-1,3-dicarbonitrile
CID 139335324
2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole
CID 160776004
N-phenyl-N-[4-[7-(8,8,14,14-tetramethyl-1,12,15-triazatetracyclo[7.7.1.02,7.013,17]heptadeca-2,4,6,9(17),10,12,15-heptaen-16-yl)-9H-fluoren-2-yl]phenyl]naphthalen-2-amine
CID 146652921
4-[10-[3-(4,6-diphenylpyrimidin-2-yl)phenyl]-9,9-dimethylacridin-2-yl]aniline
CID 89183043
9-[4-[4-[2,6-bis(3-methylphenyl)pyrimidin-4-yl]phenyl]phenyl]-3-N,6-N-bis(4-methylphenyl)-3-N,6-N-diphenylcarbazole-3,6-diamine
CID 126730253
3-[3-(9,9-dimethyl-10-phenylacridin-2-yl)phenyl]-N-phenyl-N-(4-phenylphenyl)aniline;4-[9,9-dimethyl-10-[4-(2-phenylphenyl)phenyl]acridin-2-yl]-N,N-diphenylaniline;N-[4-[9,9-dimethyl-10-(5-tricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,5,11,13-hexaenyl)acridin-2-yl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine
CID 159066790
N-naphthalen-2-yl-N-phenyl-5-(8,8,14,14-tetramethyl-1-azapentacyclo[11.7.1.02,7.09,21.015,20]henicosa-2(7),3,5,9,11,13(21),15,17,19-nonaen-5-yl)naphthalen-1-amine
CID 70893250

Frequently Asked Questions

What is the IUPAC name of 10-[8-[4,6-bis(4-methylphenyl)pyrimidin-2-yl]-5,12-dihydrotetracen-2-yl]-9,9-dimethylacridine;2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide;8-[4-(3,5-dimethylphenyl)-6-ethylquinolin-8-yl]-N,N-bis(4-methylphenyl)-6,11-dihydrotetracen-2-amine;8-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-N,N-bis(3-methylphenyl)-6,11-dihydrotetracen-2-amine;5-[8-(4-methyl-N-(4-methylphenyl)anilino)-6,11-dihydrotetracen-2-yl]benzene-1,3-dicarbonitrile?
The IUPAC name of 10-[8-[4,6-bis(4-methylphenyl)pyrimidin-2-yl]-5,12-dihydrotetracen-2-yl]-9,9-dimethylacridine;2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide;8-[4-(3,5-dimethylphenyl)-6-ethylquinolin-8-yl]-N,N-bis(4-methylphenyl)-6,11-dihydrotetracen-2-amine;8-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-N,N-bis(3-methylphenyl)-6,11-dihydrotetracen-2-amine;5-[8-(4-methyl-N-(4-methylphenyl)anilino)-6,11-dihydrotetracen-2-yl]benzene-1,3-dicarbonitrile (CID 161249741) is 10-[8-[4,6-bis(4-methylphenyl)pyrimidin-2-yl]-5,12-dihydrotetracen-2-yl]-9,9-dimethylacridine;2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide;8-[4-(3,5-dimethylphenyl)-6-ethylquinolin-8-yl]-N,N-bis(4-methylphenyl)-6,11-dihydrotetracen-2-amine;8-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-N,N-bis(3-methylphenyl)-6,11-dihydrotetracen-2-amine;5-[8-(4-methyl-N-(4-methylphenyl)anilino)-6,11-dihydrotetracen-2-yl]benzene-1,3-dicarbonitrile.
What is the SMILES notation for 10-[8-[4,6-bis(4-methylphenyl)pyrimidin-2-yl]-5,12-dihydrotetracen-2-yl]-9,9-dimethylacridine;2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide;8-[4-(3,5-dimethylphenyl)-6-ethylquinolin-8-yl]-N,N-bis(4-methylphenyl)-6,11-dihydrotetracen-2-amine;8-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-N,N-bis(3-methylphenyl)-6,11-dihydrotetracen-2-amine;5-[8-(4-methyl-N-(4-methylphenyl)anilino)-6,11-dihydrotetracen-2-yl]benzene-1,3-dicarbonitrile?
The canonical SMILES for 10-[8-[4,6-bis(4-methylphenyl)pyrimidin-2-yl]-5,12-dihydrotetracen-2-yl]-9,9-dimethylacridine;2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide;8-[4-(3,5-dimethylphenyl)-6-ethylquinolin-8-yl]-N,N-bis(4-methylphenyl)-6,11-dihydrotetracen-2-amine;8-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-N,N-bis(3-methylphenyl)-6,11-dihydrotetracen-2-amine;5-[8-(4-methyl-N-(4-methylphenyl)anilino)-6,11-dihydrotetracen-2-yl]benzene-1,3-dicarbonitrile is CC1(C)c2ccccc2N(c2ccc3cc4c(cc3c2)Cc2ccc(-c3ccc5c(c3)Sc3ccccc3S5(=O)=O)cc2C4)c2ccccc21.CCc1cc(-c2ccc3c(c2)Cc2cc4ccc(N(c5ccc(C)cc5)c5ccc(C)cc5)cc4cc2C3)c2nccc(-c3cc(C)cc(C)c3)c2c1.Cc1ccc(-c2cc(-c3ccc(C)cc3)nc(-c3ccc4cc5c(cc4c3)Cc3ccc(N4c6ccccc6C(C)(C)c6ccccc64)cc3C5)n2)cc1.Cc1ccc(N(c2ccc(C)cc2)c2ccc3c(c2)Cc2cc4ccc(-c5cc(C#N)cc(C#N)c5)cc4cc2C3)cc1.Cc1cccc(N(c2cccc(C)c2)c2ccc3cc4c(cc3c2)Cc2ccc(-c3ccc(-c5nnc(-c6ccccc6)n5-c5ccccc5)cc3)cc2C4)c1.
What is the InChIKey of 10-[8-[4,6-bis(4-methylphenyl)pyrimidin-2-yl]-5,12-dihydrotetracen-2-yl]-9,9-dimethylacridine;2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide;8-[4-(3,5-dimethylphenyl)-6-ethylquinolin-8-yl]-N,N-bis(4-methylphenyl)-6,11-dihydrotetracen-2-amine;8-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-N,N-bis(3-methylphenyl)-6,11-dihydrotetracen-2-amine;5-[8-(4-methyl-N-(4-methylphenyl)anilino)-6,11-dihydrotetracen-2-yl]benzene-1,3-dicarbonitrile?
The InChIKey is VBCONSFVMNJRCT-UHFFFAOYSA-N. The full InChI is InChI=1S/C52H40N4.C51H41N3.C51H44N2.C45H33NO2S2.C40H29N3/c1-35-11-9-17-48(27-35)55(49-18-10-12-36(2)28-49)50-26-25-42-31-44-32-43-29-40(23-24-41(43)30-45(44)33-46(42)34-50)37-19-21-39(22-20-37)52-54-53-51(38-13-5-3-6-14-38)56(52)47-15-7-4-8-16-47;1-32-13-17-34(18-14-32)46-31-47(35-19-15-33(2)16-20-35)53-50(52-46)38-22-21-36-25-41-29-42-30-43(24-23-37(42)26-40(41)28-39(36)27-38)54-48-11-7-5-9-44(48)51(3,4)45-10-6-8-12-49(45)54;1-6-36-24-49(51-50(25-36)48(19-20-52-51)44-22-34(4)21-35(5)23-44)39-12-11-37-26-42-30-43-31-47(18-13-38(43)27-41(42)29-40(37)28-39)53(45-14-7-32(2)8-15-45)46-16-9-33(3)10-17-46;1-45(2)37-9-3-5-11-39(37)46(40-12-6-4-10-38(40)45)36-19-17-30-23-33-24-32-21-28(15-16-29(32)22-34(33)25-35(30)26-36)31-18-20-44-42(27-31)49-41-13-7-8-14-43(41)50(44,47)48;1-26-3-10-38(11-4-26)43(39-12-5-27(2)6-13-39)40-14-9-32-20-35-21-34-18-30(33-16-28(24-41)15-29(17-33)25-42)7-8-31(34)19-36(35)22-37(32)23-40/h3-29,31,33-34H,30,32H2,1-2H3;5-25,27-28,30-31H,26,29H2,1-4H3;7-25,27-28,30-31H,6,26,29H2,1-5H3;3-21,23,25-27H,22,24H2,1-2H3;3-19,21,23H,20,22H2,1-2H3.
What are the key properties of 10-[8-[4,6-bis(4-methylphenyl)pyrimidin-2-yl]-5,12-dihydrotetracen-2-yl]-9,9-dimethylacridine;2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide;8-[4-(3,5-dimethylphenyl)-6-ethylquinolin-8-yl]-N,N-bis(4-methylphenyl)-6,11-dihydrotetracen-2-amine;8-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-N,N-bis(3-methylphenyl)-6,11-dihydrotetracen-2-amine;5-[8-(4-methyl-N-(4-methylphenyl)anilino)-6,11-dihydrotetracen-2-yl]benzene-1,3-dicarbonitrile?
10-[8-[4,6-bis(4-methylphenyl)pyrimidin-2-yl]-5,12-dihydrotetracen-2-yl]-9,9-dimethylacridine;2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide;8-[4-(3,5-dimethylphenyl)-6-ethylquinolin-8-yl]-N,N-bis(4-methylphenyl)-6,11-dihydrotetracen-2-amine;8-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-N,N-bis(3-methylphenyl)-6,11-dihydrotetracen-2-amine;5-[8-(4-methyl-N-(4-methylphenyl)anilino)-6,11-dihydrotetracen-2-yl]benzene-1,3-dicarbonitrile has a molecular weight of 3337.35 g/mol, XLogP of 60.58, 23 rotatable bonds, 0 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 10-[8-[4,6-bis(4-methylphenyl)pyrimidin-2-yl]-5,12-dihydrotetracen-2-yl]-9,9-dimethylacridine;2-[8-(9,9-dimethylacridin-10-yl)-5,12-dihydrotetracen-2-yl]thianthrene 5,5-dioxide;8-[4-(3,5-dimethylphenyl)-6-ethylquinolin-8-yl]-N,N-bis(4-methylphenyl)-6,11-dihydrotetracen-2-amine;8-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-N,N-bis(3-methylphenyl)-6,11-dihydrotetracen-2-amine;5-[8-(4-methyl-N-(4-methylphenyl)anilino)-6,11-dihydrotetracen-2-yl]benzene-1,3-dicarbonitrile is sourced from PubChem (CID 161249741), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).